News

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...
The dessert dip was initially recalled by manufacturers in late July with its risk classification raising to a Class II ...
DermaRite Industries announced​ on Friday that it was voluntarily recalling three skin-cleansing products and an anti-itch ...
More than 20 Republican attorneys general are demanding that the Trump administration reinstate safety protocols for the ...
A New York woman was sentenced to five months in prison for tampering with vials of hydromorphone and fentanyl at a surgical ...
The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug ...
Dr. David A. Kessler has outlined a legal path for Health Secretary Robert F. Kennedy Jr. to take on the food industry, while ...
Several lots of soap products distributed across the U.S. are being recalled over the possible presence of Burkholderia ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated’s (NASDAQ:INSM) Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic ...